Skip to content
Enough Ventures

Our work in deep tech and nuclear innovation.

Companies and projects we lead, support or helped build. Each is shown at the stage it has reached, with the date it was last checked.

  • Nuclear innovation

    Radion Robotics

    What it is
    A venture built on research from Brazil's national nuclear research institutes.
    What it builds
    Radiopharmaceutical production technology for nuclear medicine.
    Our role
    We lead commercialization, through our managing partner.
    Stage
    Patent family in preparation (2 of 5 submitted)
  • Deep tech

    Xelios

    What it is
    A lab automation company in formation.
    What it builds
    Lab automation for advanced cell workflows, for research use only.
    Our role
    We lead company formation, from the first workflow to a pilot.
    Stage
    Company formation in progress
  • Industrial software

    Limis

    What it is
    An industrial software company.
    What it builds
    Software that digitizes manufacturing operations.
    Our role
    We support commercial strategy, with Arkus Innovation Studios.
    Stage
    In commercial use
  • AI and innovation

    Arkus Innovation Studios

    What it is
    An AI-Native Innovation Consulting Studio.
    What it builds
    The AI Readiness Diagnostic.
    Our role
    We focus on the intersection of AI Adoption, Edge Computing, and Innovation Space Design.
    Stage
    Operating
  • Medical device

    Pedtrak

    What it is
    A medical device company founded by nurses.
    What it builds
    A device that finds and monitors pulses in the arms and legs.
    Our role
    We support commercialization, through our managing partner.
    Stage
    Founder began military service in 2026
  • Healthcare wearables

    LifeLensAR

    What it is
    A healthcare wearables company.
    What it builds
    A wearable augmented reality system for healthcare monitoring.
    Our role
    We co-founded and led the company, through our managing partner.
    Stage
    Acquired in 2025

Stages as of November 2026.

Read more about Xelios

This page is not a list of investments, a track record or an invitation to invest. Science that is not yet protected is described by its purpose and stage, not by its method.

Have science that belongs here?

We take on a small number of projects and stay close to each one.